Influenza vaccine (H1N1) v (whole virion, inactivated, prepared in cell culture)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza vaccine (H1N1) v (whole virion, inactivated, prepared in cell culture)

Drug Alias NameH1N1流感疫苗（Baxalta）H1N1全流感病毒颗粒灭活疫苗（Baxalta）Celvapan

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEU

Original Approved Date2009/03/04

Country/TerritoryEU

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaN/A

Originator CompaniesBaxalta Incorporated

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNanotherapeutics Bohumil Sro

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB01